Friday, June 19, 2026

Sillajen Presents Early BAL0891 Clinical Findings at ASCO 2026, Highlighting Safety and Early Anti-Cancer Activity

ShillaGen presented initial clinical research results of its cancer drug BAL0891 at ASCO, showcasing promising developments.

North Korea Now Letting Citizens Own Cars—for the First Time Ever

North Korea has legalized private car ownership, introducing a registration system to better track and regulate assets in the economy.

Rep. Yoon Sang Hyun Pushes for Presidential Protection, Leads Visit to Yoon Suk Yeol in Detention

Rep. Yoon plans to meet President Yoon at the Seoul Detention Center, advocating for his protection amid impeachment proceedings.

Tag: SynKIR-310

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Verismo unveils preclinical data on improved antitumor efficacy and safety of blood cancer CAR-T at AACR

HLB Innovation's SynKIR-310 shows improved antitumor activity and safety in preclinical trials, achieving 100% survival in mice.

Revolutionary CAR-T Treatment SynKIR-310 Outperforms CD19 CAR-T: What This Means for Blood Cancer Patients

Verismo Therapeutics' SynKIR-310 shows superior anti-tumor effects in preclinical studies, promising a safer CAR-T therapy for blood cancers.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.